Overview
Laura Gibson is an Infectious Disease specialist and a Pediatrics provider in Worcester, Massachusetts. Dr. Gibson is rated as an Experienced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Cryptococcosis, Cytomegalic Inclusion Disease, Cytomegalovirus Infection, and Familial Chronic Mucocutaneous Candidiasis. Dr. Gibson is currently accepting new patients.
Her clinical research consists of co-authoring 1 peer reviewed article and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Eirini Christaki is an Infectious Disease provider in Providence, Rhode Island. Dr. Christaki is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are COVID-19, Flu, Sepsis, and Pneumonia.
Dana-Farber Cancer Institute, Inc.
Lindsey Baden is an Infectious Disease provider in Boston, Massachusetts. Dr. Baden is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), Pneumonia, and HIV/AIDS. Dr. Baden is currently accepting new patients.
Brigham And Womens Physicians Organization Inc
Dr. Li is an infectious disease physician-scientist at the Brigham and Women’s Hospital and Harvard Medical School. He leads an active clinical and translational laboratory research program focused on viral detection, reservoirs and resistance, especially within the fields of HIV and COVID-19.Dr. Li is the Director of the Harvard/Brigham Virology Specialty Laboratory, the Director of the Harvard University Center for AIDS Research Clinical Core, and a member of the AIDS Clinical Trials Group (ACTG) Executive Committee. He is the protocol co-Chair of the ACTG A5308 study of ART treatment for HIV-1 controllers, the co-Chair of the A5345 study of biomarkers of HIV rebound, and the protocol virologist for A5401/ACTIV-2 Adaptive Platform Treatment Trial for Outpatients with COVID-19. Dr. Li also serves as the Deputy Editor for the Infectious Disease Society of America (IDSA) journal Open Forum Infectious Diseases and on the Editorial Advisory Board for the Journal of Infectious Diseases. Dr. Li is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are HIV/AIDS, COVID-19, Sepsis, Prostatectomy, and Nephrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ActinomycosisDr. Gibson isExperienced. Learn about Actinomycosis.
- CryptococcosisDr. Gibson isExperienced. Learn about Cryptococcosis.
- Cytomegalic Inclusion DiseaseDr. Gibson isExperienced. Learn about Cytomegalic Inclusion Disease.
- Cytomegalovirus InfectionDr. Gibson isExperienced. Learn about Cytomegalovirus Infection.
- Familial Chronic Mucocutaneous Candidiasis